As the number of drug resistant pulmonary TB is increasing around the world, the number of drug resistant TB with extrapulmonary manifestations are also on rise. However, there is surprisingly scant information in medical literatures on prevalence and impact of extrapulmonary drug-resistant TB Aim:This study aimed to detect and isolate Mycobacterium Tuberculosis Complex (MTC or MTBC) strains from extrapulmonary samples then determine the drug resistance pattern of these strains to antituberculus drugs.
INTRODUCTION
At present, the most serious issue with TB control programme is emergence of multi and extensively drug resistant Mycobacterium tuberculosis strain worldwide (Singh & Jain, 2015). Multidrug-resistant tuberculosis (MDR-TB) is defined as tuberculosis caused by bacteria resistant to the two first-line antituberculosis drugs rifampicin and isoniazid (Dheda et al., 2017), While extensively drug resistant tuberculosis( XDR -TB )is defined as TB with resistance to at least isoniazid, rifampin, a fluoroquinolone, and 1 of 3 injectable second-line drugs (amikacin, kanamycin, or 
capreomycin) (Banerjee et al., 2008).
Several countries, including India, Iran and South Africa, have also reported totally drug-resistant (TDR)-TB strains that are apparently resistant to all tested first-line, second-line and thirdline anti-TB drugs (Dheda et al.., 2017). However, this (TDR-TB) disease entity is currently not endorsed by WHO since drug susceptibility testing (DST) for many secondline/third-line drugs are poorly reproducible (ranging from 50% to 80%), the number of drugs tested varies among reference laboratories and the existing category of XDR-TB already encompasses extensive drug resistance to most active anti-TB drugs (Cegielski et al., 201 2). Drug resistant-extrapulmonary tuberculosis is considered reason to worry due to following reasons (Singh & Jain, 2015): (I) Drug resistance in cases of EPTB is increasing and now it cannot be considered as rare. (II) Accurate and timely diagnosis and drug susceptibility testing are very difficult and may result into high morbidity and mortality.(III) DR-EPTB is often difficult to treat due to poor penetration of some key antitubercular drugs into extra-pulmonary sites (especially in CSF)(IV) HIV and young age are independent key risk factors (v) Although not contagious but it may co-exist with highly contagious pulmonary manifestation. DR-EPTB can arise through acquired-DR-TB from previous improper TB treatment or transmission of DR-strains. A recent metaanalysis demonstrated that when PTB and EPTB coexisted, a higher rate of DR-TB was observed than PTB alone (Pooja et al., 2018).
MATERIALS AND METHODS
The study was conducted from September 2016 to January 2018 at Medial Microbiology & Immunology Department, Sohag Faculty of Medicine. The study included patients in different departments at Sohag University Hospital and private clinics at Sohag Governorate who suspected by clinician to have (EPTB).
Specimen collection & processing
One hundred clinical specimens were collected during the study period and screened for mycobacteria species. These include 45 urine samples, 35 stool samples and 20 other samples (rather than urine &stool) include pleural fluid samples (5), ascitic fluid samples (3), biopsies from skin lesions (3), pus from chest abscess (2), cervical lymph nodes biopsy (2), pus from breast abscess (2), biopsy from laryngeal mass (1), biopsy from vocal cord thickening (1) and swab from skin sinus (1). Tow smears were prepared from each sample one from the sample directly and another one after decontamination and concentration process. The smears were stained by ZiehlNeelsen stain for detection of acid fast bacilli. The contaminated samples as stool samples were decontaminated by Petroff method. After decontamination of samples sterility test was done for each sample by inoculation on three agar plates (nutrient agar, blood agar and MacConkey) in addition to L.J media and incubate for 3 days if no growth this mean good decontamination but if growth appear on any plate this mean imperfect decontamination and the test repeated again. After that inoculation on Lowenstein Jensen media (LJ) was done with examination once weekly for 12 weeks and record number of days required for colonies to become macroscopically visible and if the pigment was produced or not to differentiate between MTC and NTM Identification of isolates: The isolates from positive mycobacterial culture were identified biochemiclly by sensitivity to inhibitory substances PNB (Para nitro benzoic) acid t and TCH (thiophene-2-carboxylic acid hydrazide), nitrate reduction test and niacin test. Mycobacterium tuberculosis complex (MTC) strains were sensitive to PNB, resistant or sensitive for TCH and had positive niacin &positive nitrate reduction test. The isolates were further identified by conventional PCR. The used primers were specific for identification of MTC by pair of primers designed to amplify an insertion sequence IS6110. The sequence of these FP1 and RP2 primers were: 5'-CCT GCGAGC GTA GGC GTC GG3 and 5 ' CTC GTC CAGCGC CGC TTC GG 3 ' , respectively). 
RESULTS
Out from 100 extrapulmonary samples analyzed, 66 samples were positive for mycobacterial infection. Those positive samples were 46 from male and 20 from female with a mean of age 45.8. The overall positivity for mycobacteria observed through ZN staining and LJ culture was 47 and 66 respectively. This mean that Sensitivity, specificity, positive predictive value (PPV) and negative predicative value (NPV) of ZN stain method in comparison with L.J Culture media method were 71.21%, 100%, 100% and 64.15% respectively. The incidence of MTC in samples had negative film with positive culture was (16/19), representing 84.2% while the incidence of MTC in samples had positive film with positive culture was (37/53), representing 69.8% of total MTC strains in all samples During our study period, all positive mycobacterialisolates(66) were tested by both biochemical tests and PCR (the gold standard test) for identification of MTC. Fifty six isolates were identified as MTC and 10 isolates as NTM by biochemical tests, whereas 53 isolates were identified as MTC and 13 isolates as NTM by PCR. So sensitivity, specificity, positive predictive value (PPV), negative predicative value (NPV) of biochemical tests in comparison with PCR method were 100%, 76.9%, 94.6% and 100respectively. Antibiotic susceptibility pattern of MTB complex strains was done for MTC strains as shown in table (2). The incidence of MDR among EPTB cases was 9.4% while incidwnce of XDR among EPTB cases was 1.9%. of biochemicaltests compared to PCR method were 96 and 100%, respectively and Positive predicted value (PPV) and negative predicted value (NPV) were 100 and 92%, respectively. In our study the incidence of MTC was 53% from all collected extrapulmonary samples this was higher than another study conducted in India in which the incidence of MTBC was 30% from all collected extrapulmonary samples (Gupta et al., 2016) . In our study MTC strains were mostly isolated from urine samples ( 24 isolates, representing 45% of total number of EPTB isolates), followed by stool samples ( 15 isolates, representing 28% ) then other extrapulmonary samples (14 isolates, representing 26.4%, 5 strains from pleural fluid, 3 strains from ascitic fluid, 2 strains from cervical lymph nodes biopsies, one strain from each biopsy from skin nodule &ulceration, Biopsy from laryngeal mass, Biopsy from vocal cord lesion & Pus from chest abscess). This means that renal TB was the commonest site of EPTB followed by TB enteritis, TB pleural effusion, TB ascites and lymphadenitis then equal frequency for each cutaneous TB, laryngeal TB, vocal cord TB and TB in chest wall.This was in accordance with Ranjan and Sharma, (2010) who reported that genitourinary tract (GUT) is the most common site of EPTB. This high percentage of renal TB and TB enteritis may reflect higher rate of suspecion by clinician for renal TB and TB enteritis than previous studies and improvement in diagnostic techniques in our study.
On other hand, it differ from a study in Sohag from 2010 to 2014 by Mohammadien et al. (2017) which depended mainly on histopathological diagnosis (in percent 68%) but Bacteriological tests were low in percent (11%). The sites of EPTB were in TB lymphadenitis (187 cases, 37.4%), TB pleural effusion (106 cases, 21.2%), skeletal TB (90 cases, 18%) which included (75cases, 15%) that were pott'sdisase and (5 cases, 1%) were articular TB (3 cases with knee arthritis, 1 case hip arthritis, and 1 case elbow arthritis) and (10 cases, 2%) with extraspinal osteomyelitis(7 cases with rib osteomyelitis and 3 cases with femur osteomyelitis), TB ascites (37 cases,7.4%), TB enteritis (21 cases, 4.2%), cutaneous TB (10 cases, 2%), genitourinary TB (30 cases, 6%) which included (22 cases, 4.4%) renal TB and (4 cases, 0.8) were male genital TB cases (3 cases TB epididymitis and 1 case testicular TB)and (4 cases, 0.8%) were female genital TB cases (3 cases TB salpingitis, 1 case TB endometritis), CNS TB (10 cases, 2%) which included (7 cases, 1.4%) were TB meningitis and (3 cases, 0.6%) were TB tuberculoma, pericardial effusion (5 cases, 1%), TB mastitis (3 cases, 0.6%), TB laryngitis (1 case, 0.2%). Also at Aswan Chest Hospital, the most common affected extrapulmonary TB site was lymph nodes followed by pleura, and then bone(27.4%,25%, and 14.9%, respectively (Sobh et al., 2016).It differ also from Hibah study (2015) in El-Behira Governorate, Egypt, who reportedPleural TB constituted 63.3% ( n = 1341) of all EPTB cases followed by Lymph node TB constituted 20% (n = 427) of EPTB cases. Bone TB constituted 7.5% (n = 157) cases, genital TB constituted 3.3% ( n = 70) of all EPTB cases , Renal TB constituted 1.6% (n = 34) of allEPTB cases. Also differ from Peto 3%) , genitourinary (6.5%), meningeal (5.4%), peritoneal (4.9%), and unclassified EPTB (11.8%) cases.These differences suggest that the dynamics of extrapulmonary tuberculosis epidemiology may be specific to geographic location and population and also affected by method of diagnosis and length of period during which the samples collected. In our study the incidence of NTM represented 13% from total collected extrapulmonary specimen. It was in accordance with a study from a Northern Indian population in which 18.2% of the NTM were recovered fromextrapulmonary specimens (Umrao et al., 2016). And also our result was near to Chakrabarti et al. (1990) and Das et al. (1982) they reported incidence of NTM from different regions of India were 7.4% and 8.3% respectively. In our study NTM strains were mostly isolated from stool samples ( 7 isolates, representing 53.8% of total number of NTM isolates), followed by urine samples (representing 23%), Pus from breast abscess (representing 15%), then Swab from skin sinus (representing 7.6%). This was different from a study by Henkle et al. (2017) ZN staining) .In spite of the high specificity of ZN staining method, it showed variable and low sensitivity which is mainly attributed to the degree of mycobacterium shedding in a sample. Diagnosis extra-pulmonary tuberculosis (EPTB) in smear-negative patients can be difficult. In our study total number of positive culture for MTBC from total extrapulmonary samples were 53. The incidence of positive film in samples had positive culture for MTBC was 37/53 representing 69.8% of total MTBC strains while incidence of negative film in samples had positive culture for MTBC was(16/53), representing 30.2% of total MTBC strains.This result was differing from a study performed at Italy, In which the total number of positive culture for MTC from extrapulmonary samples were 112. The incidence of positive film in samples had positive culture for MTBC was 15/112 (representing 13.4%), while incidence of negative film in samples had positive culture for MTBC was 97/112 ( 86.6%), in this study sensitivity of microscopy was poor probably due to Ziehl-Neelsen staining before sample concentration but in our study concentration of samples before staining was done and this raise the sensitivity of ZN smear (  Lombardi1 et al., 2017) . Antibiotic susceptibility pattern of isolated MTBC strains in our study showed that the strains had the highest sensitivity rates to both Ethambutol and Kanamycin (each represented 98.1%), Capreomycin( 96.2%), Streptomycin(94.3%), Amikacin (92.5%) then Rifampicin( 90.6%). Meanwhile, the highest resistance rates were to Isoniazid (13.2%) ,Ofloxacin(11.3%), Rifampicin(9.4%), Amikacin(7.5%). In another study by Nair et al. (2009) showed resistance pattern of MTBC extrapulmonary towards first and second line drugs by LJ proportion method, it supported our result that the strains had highest resistance to isoniazid 16/54 (29.6%) and highest sensitivity to ethambutol but it differ from our result in the following resistance after isoniazid. It followed by rifampcin 8/54 (14.8%), pyrazinamide 7/54(12.9%), ethionamide, kanamycin and capreomycin (each 6/54represented 11.1%) then ciprofloxacin and amikacin(each 5/54 represented 9.2%) then ethambutol 4/54(7.4%).Also Pollett et al. (2016) reporteddrugsusceptibility testing results (by phenotypic or genotypic methods) which were lower than our result. There were :5% (3/66) had isoniazid resistance, 2% (1/66) had pyrazinamide resistance, 2% (1/66) had rifampicin resistance. In our result drug resistance for the first-line antituberculos drugs were: Isoniazid (13.2%), rifampicin ( 9.4%) , Ethambutol (1.9%), Streptomycin (5.7%), while in a study done in the Netherlands from 1998 to 2005 and amounted the levels of drug resistance for the first-line antituberculosis drugs 7.5% for isoniazid, 1.4% for rifampin, 8.5% for streptomycin, and 1.0% for ethambutol (van et al., 2007) . Alsoisoniazid resistance was lower in another study by Kumariet al. (2016) who reported INH mono resistance in 1/51
(1.96%).In another study isoniazid monoresistance was (9.9%). rifampicin monoresistance was (2.1%), streptomycin monoresistance was (0.5%), and ethambutolmonoresistancewas(0.9%). prevalence of ofloxacinresistance i.e. pre-XDR.TB among MDR-TB patients was 17%. ( Sharma et al., 2017) .Also in a study by Kohli et al. (2016) , DST by proportion method showed near result to our study in the incidence of rifampcin resistance 6.7%, isoniazid resistance 14.7%, but had higher result in incidence of streptomycin resistance 22.7%, ethambutol resistance 9.3%. In our study MDR represented 9.4% of total MTBC isolated strains. Though very few data is available on drug resistance in extra pulmonary tuberculosisour finding is supported by data from previous studies which reported 12.5% MDR-EPTB in Nepal and 10% in Delhi India (Gurung et al., 2010) (Sachdeva et al., 2002). Also our result was higher than those reported by Qian et al. (2018) who identified Multidrug-resistant TB (MDR-TB)in5/1259( 0.4%)and Pollett et al. (2016) who reportednone had multi-drug resistance while, our result was lower than that reported by Kumari et al. (2016) who identified MDR-TB in 14/51 (27.45%). In another study, prevalence of MDR-TB was 3% in treatment -naive & 14.5% in treatment -experienced EPTBcases (Sharma et al., 2017) . In our study XDR: represented 1.9% of total MTBC isolated strains these results in agreement with that of Sharma et al. (2017) Nene et al. (2016) who reported XDR among EPTB cases 2/29 (representing 6.9%). Our findings are also supported by data accrued from different countries that found the prevalence of MDR may lie between 1%-69% of total of EPTB cases; whereas, the proportion of resistant cases to any one antituberculosis drug is about 10%-75%. The wide variation in proportion of drug resistant EPTB among different studies is probably due to variation in study settings, burden of MDR-TB and quality of medical services in particular region, demographic characteristic and HIV status of patients, types of EPTB cases investigated, sample size and its selection criteria etc (Singh & Jain, 2015). In conclusion, we got a significant number of MTC isolated from extra pulmonary cases of our Governorate which suggests that this form of TB has also reached an alarming level so this uncommon form of tuberculosis cannot be overlooked and due attention on the patients of extra pulmonary tuberculosis should be given. Antibiotic susceptibility pattern should be done for each of isolated MTC strains to optimize efficient anti-TB treatment and to avoid development of MDR-TB which ultimately develop to XDR-TB. 
